Prelude Therapeutics (PRLD) Prepaid Assets (2019 - 2026)

Prelude Therapeutics has reported Prepaid Assets for 8 years, with the latest figure at $3.0 million in Q1 2026.

• Quarterly Prepaid Assets fell 8.71% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 8.71% YoY) and the FY2025 annual result came in at $2.5 million, up 8.64% from the prior year.
• Prepaid Assets improved to $3.0 million in Q1 2026 per PRLD's latest filing, from $2.5 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $5.2 million in Q2 2023 and troughed at $2.3 million in Q4 2024.
• A 5-year average of $3.2 million and a median of $3.0 million in 2023 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2023 and 2024: Prepaid Assets soared 125.14% in 2023, then tumbled 45.03% in 2024.
• Over 5 years, Prepaid Assets stood at $2.7 million in 2022, then climbed by 0.08% to $2.7 million in 2023, then fell by 14.05% to $2.3 million in 2024, then rose by 8.64% to $2.5 million in 2025, then advanced by 22.64% to $3.0 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $3.0 million, $2.5 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.